Клинический разбор в общей медицине

Представлены четыре клинических наблюдения, обсуждавшихся на Международном конгрессе «Кардиоторакальная радиология» (Москва, апрель 2026 г.) и иллюстрирующих сложности дифференциальной диагностики заболеваний органов дыхания. На примерах гранулематоза с полиангиитом, эозинофильного гранулематоза с полиангиитом, эмфизематозных изменений легких и воспалительной миопатии продемонстрировано значение комплексной оценки клинических, лабораторных и лучевых данных в рамках мультидисциплинарного подхода.

Ключевые слова: дифференциальная диагностика, компьютерная томография, заболевания органов дыхания, васкулит, интерстициальное заболевание легких.

1. Levy AG. Radiograms as an aid to diagnosis in lung diseases. Post Grad Med J 1926;1:158-9.

2. Jennette JC, Falk RJ, Bacon PA et al. 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013;65(1):1-11. DOI: 10.1002/art.37715

3. Hellmich B, Sanchez-Alamo B, Schirmer JH et al. EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update. Ann Rheum Dis 2024;83(1):30-47. DOI: 10.1136/ard-2022-223764

4. Lanham JG, Elkon KB, Pusey CD, Hughes GR. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore) 1984;63(2):65-81. DOI: 10.1097/00005792-198403000-00001

5. White J, Dubey S. Eosinophilic granulomatosis with polyangiitis: A review. Autoimmun Rev 2023 Jan;22(1):103219. DOI: 10.1016/j.autrev.2022.103219

6. Satoh K, Kobayashi T, Misao T. CT assessment of subtypes of pulmonary emphysema in smokers. Chest 2001;120:725-9.

7. Shapiro SD. Proteolysis in the lung. Eur Respir J 2003;22:30S-32S.

8. Fletcher CM, Pride NB. Definitions of emphysema, chronic bronchitis, asthma, and airflow obstruction: 25 years on from the Ciba symposium. Thorax 1984;39(2):81-5. 

9. Radzikowska E, Wiatr E, Jarzemska A et al. Pulmonary Langerhans-cell histiocytosis – Analysis of 57 cases. Eur Respir J 2011;38(Suppl 55):637.

10. Vassallo R, Ryu JH, Schroeder DR et al. Clinical outcomes of pulmonary Langerhans’cell histiocytosis in adults. N Engl J Med 2002;346(7):484-90.

11. Mason RH, Foley NM, Branley HM et al. Pulmonary Langerhans cell histiocytosis (PLCH): a new UK register. Thorax 2014;69(8):76-67.

12. Howarth DM, Gilchrist GS, Mullan BP et al. Langerhans cell histiocytosis: diagnosis, natural history, management, and outcome. Cancer 1999;85(10):2278-90.

13. Khoo T, Lilleker JB, Thong BY et al. Epidemiology of the idiopathic inflammatory myopathies. Nat Rev Rheumatol 2023;19(11):695-712. DOI: 10.1038/s41584-023-01033-0

14. Lundberg IE, Fujimoto M, Vencovsky J et al. Idiopathic inflammatory myopathies. Nat Rev Dis Primers 2021;7(1):86. DOI: 10.1038/s41572-021-00321

15. Palmucci S, Di Mari A, Cancemi G et al. Clinical and Radiological Features of Interstitial Lung Diseases Associated with Polymyositis and Dermatomyositis. Medicina (Kaunas) 2022 Nov 30;58(12):1757. DOI: 10.3390/medicina58121757

16. Kannappan R, Kumar R, Cichelli K, Brent LH. A Review of Myositis-Associated Interstitial Lung Disease. J Clin Med 2024 Jul 11;13(14):4055. DOI: 10.3390/jcm13144055

17. Oldroyd AGS, Callen JP, Chinoy H et al. International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative. Nat Rev Rheumatol 2023;19:805-17. DOI: 10.1038/s41584-023-01045-w

18. Sun KY, Fan Y, Wang YX et al. Prevalence of interstitial lung disease in polymyositis and dermatomyositis: A meta-analysis from 2000 to 2020. Semin Arthritis Rheum 2021 Feb;51(1):175-91. DOI: 10.1016/j.semarthrit.2020.11.009

19. Bobirca A, Alexandru C, Musetescu AE et al. Anti-MDA5 Amyopathic Dermatomyositis-A Diagnostic and Therapeutic Challenge. Life (Basel) 2022 Jul 23;12(8):1108. DOI: 10.3390/life12081108

20. Sehgal S, Patel A, Chatterjee S et al. Idiopathic inflammatory myopathies related lung disease in adults. Lancet Respir Med 2025;13(3):272-88. DOI: 10.1016/S2213-2600(24)00267-4